Loading live market data…

Cerevel Therapeutics Holdings, Inc.

NASDAQ:CERE

$44.96 USD

$0.33 (0.74%)

Volume
15.03M
Average Volume
2.11M
Market Capitalization
$8.19B
P/E Ratio
-16.84
Dividend Yield
0.00%
Price Target
$33.50
Year High
$44.99
Year Low
$19.59
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.92
Source Headline

Get CERE Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

CERE Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$33.50

2 analysts

CERE Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-02-16 Mizuho Maintain Neutral Neutral
2023-12-28 JP Morgan Maintain Neutral Neutral
2023-12-22 Jefferies Downgrade Buy Hold
2023-12-08 TD Cowen Downgrade Outperform Market Perform
2023-12-07 Piper Sandler Downgrade Overweight Neutral
2023-12-07 Cantor Fitzgerald Downgrade Overweight Neutral
2023-12-07 HC Wainwright & Co. Downgrade Buy Neutral
2023-11-02 Morgan Stanley Maintain Overweight Overweight
2023-08-07 Mizuho Maintain Neutral Neutral
2023-08-06 Mizuho Maintain Neutral Neutral
2023-08-03 HC Wainwright & Co. Maintain Buy Buy
2023-08-03 Morgan Stanley Maintain Overweight Overweight
2023-08-03 B of A Securities Downgrade Buy Neutral
2023-08-02 HC Wainwright & Co. Maintain Buy Buy
2023-08-02 B of A Securities Downgrade Buy Neutral
2023-08-02 Morgan Stanley Maintain Overweight Overweight
2023-05-26 Goldman Sachs Maintain Neutral Neutral
2023-05-23 Goldman Sachs Maintain Neutral Neutral
2023-05-22 Goldman Sachs Maintain Neutral Neutral
2023-05-08 Mizuho Maintain Neutral Neutral
2023-05-07 Mizuho Maintain Neutral Neutral
2023-05-04 Wells Fargo Upgrade Equal Weight Overweight
2023-05-03 Wells Fargo Upgrade Equal Weight Overweight
2023-04-10 TD Cowen Maintain Outperform Outperform
2023-04-03 HC Wainwright & Co. Maintain Buy Buy
2023-03-17 JP Morgan Downgrade Overweight Neutral
2023-03-16 JP Morgan Downgrade Overweight Neutral
2023-03-09 Mizuho Maintain Neutral Neutral
2023-03-08 Mizuho Maintain Neutral Neutral
2023-02-23 HC Wainwright & Co. Maintain Buy Buy
2023-02-23 Wells Fargo Downgrade Overweight Equal Weight
2023-02-23 Morgan Stanley Maintain Overweight Overweight
2023-02-22 Goldman Sachs Maintain Neutral Neutral
2023-02-22 Morgan Stanley Maintain Overweight Overweight
2023-02-22 Wells Fargo Downgrade Overweight Equal Weight
2023-02-22 HC Wainwright & Co. Maintain Buy Buy
2023-02-21 Goldman Sachs Maintain Neutral Neutral
2022-12-06 JP Morgan Maintain Overweight Overweight
2022-12-05 JP Morgan Maintain Overweight Overweight
2022-11-10 Mizuho Maintain Neutral Neutral
2022-11-09 Mizuho Maintain Neutral Neutral
2022-11-09 HC Wainwright & Co. Maintain Buy Buy
2022-11-08 HC Wainwright & Co. Maintain Buy Buy
2022-11-01 Loop Capital Maintain Buy Buy
2022-10-20 B of A Securities Maintain Buy Buy
2022-09-29 Cantor Fitzgerald Maintain Overweight Overweight
2022-09-26 Wells Fargo Maintain Overweight Overweight
2022-09-21 Goldman Sachs Maintain Neutral Neutral
2022-09-20 Goldman Sachs Maintain Neutral Neutral
2022-09-13 Evercore ISI Group Maintain Outperform Outperform
2022-08-23 Mizuho Maintain Neutral Neutral
2022-08-22 Morgan Stanley Maintain Overweight Overweight
2022-08-22 Mizuho Maintain Neutral Neutral
2022-08-21 Morgan Stanley Maintain Overweight Overweight
2022-08-09 Stifel Maintain Buy Buy
2022-08-08 Stifel Maintain Buy Buy
2022-08-03 Mizuho Maintain Neutral Neutral
2022-08-02 Mizuho Maintain Neutral Neutral
2022-07-07 Mizuho Maintain Neutral Neutral
2022-05-24 Goldman Sachs Maintain Neutral Neutral
2022-05-23 Goldman Sachs Maintain Neutral Neutral
2022-02-15 Goldman Sachs Maintain Neutral Neutral
2022-01-05 JP Morgan Maintain Overweight Overweight
2021-12-16 HC Wainwright & Co. Maintain Buy Buy
2021-09-07 Morgan Stanley Maintain Overweight Overweight
2021-09-06 Morgan Stanley Maintain Overweight Overweight
2021-06-18 Morgan Stanley Maintain Overweight Overweight
2020-12-10 Goldman Sachs Maintain Buy Buy
2020-11-23 Jefferies Maintain Buy Buy
2020-11-09 Stifel Maintain Buy Buy
2013-11-24 Sidoti & Co. Downgrade Buy Neutral
2013-07-11 Piper Sandler Downgrade Overweight Neutral
2013-04-11 Piper Sandler Maintain Overweight Overweight
2013-04-11 Goldman Sachs Maintain Neutral Neutral
2013-01-10 Barclays Maintain Overweight Overweight
2012-11-20 Barclays Maintain Overweight Overweight
2012-09-13 Piper Sandler Maintain Overweight Overweight
2012-07-12 Piper Sandler Maintain Overweight Overweight